|
MTRF1L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
6.02530000000101E-05 |
| Normal-vs-Stage3 |
1.33226762955019E-15 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
1.087510E-02 |
| Stage1-vs-Stage3 |
3.848100E-02 |
| Stage1-vs-Stage4 |
2.392700E-04 |
| Stage2-vs-Stage3 |
5.773800E-04 |
| Stage2-vs-Stage4 |
1.60506999999921E-05 |
| Stage3-vs-Stage4 |
1.192810E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.00969999028422E-09 |
| Normal-vs-Asian |
8.26680000010072E-08 |
| Caucasian-vs-AfricanAmerican |
2.712400E-01 |
| Caucasian-vs-Asian |
1.049030E-01 |
| AfricanAmerican-vs-Asian |
6.642300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
3.691400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62925228863742E-12 |
| Normal-vs-Age(41-60Yrs) |
3.33066907387547E-16 |
| Normal-vs-Age(61-80Yrs) |
2.07770467497426E-11 |
| Normal-vs-Age(81-100Yrs) |
1.12050000000696E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.540600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.374800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.245500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.333000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.768780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.578000E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.900750E-03 |
| Classical-VS-Follicular |
2.185600E-04 |
| Classical-VS-Other |
6.855600E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.49480000044555E-07 |
| Tall-VS-Other |
5.090600E-01 |
| Tall-VS-Normal |
1.33226762955019E-15 |
| Follicular-VS-Other |
1.406770E-01 |
| Follicular-VS-Normal |
3.63130000000655E-05 |
| Other-VS-Normal |
4.783400E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.19775325610772E-13 |
| Normal-vs-N1 |
1.0822454044046E-12 |
| N0-vs-N1 |
5.540400E-02 |
|
|
